Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
NAFDAC has intensified enforcement against counterfeit pharmaceuticals and regulatory violations, including blacklisting a manufacturer, while also promoting public health initiatives and providing guidance on medical device reporting. These actions signal a stricter compliance environment for pharmaceutical and medical device businesses, with potential ripple effects on importers, distributors, and healthcare providers. Businesses must enhance due diligence, ensure product authenticity, and stay abreast of NAFDAC alerts to avoid penalties.
Pharmaceuticals
Medical Devices
Food and Beverages
Healthcare
Import/Export
Manufacturing
NAFDAC joins the Federal Ministry of Health and Social Welfare, nutrition partners, and the global community in celebrating World Breastfeeding Week 2026
NAFDAC
NAFDAC celebrates World Breastfeeding Week 2026, emphasizing the importance of breastfeeding and likely promoting safe nutrition practices.
May lead to increased awareness and potential regulations on breast milk substitutes and infant nutrition products.
Handling Manufacturer Investigation Reports for Medical Devices and IVDs
NAFDAC
NAFDAC provides guidance on handling Manufacturer Investigation Reports (MIRs) for medical devices and IVDs to ensure safety and compliance.
Medical device and IVD manufacturers and importers must implement robust complaint and adverse event reporting processes to meet NAFDAC expectations.
Blacklisting of Onifam Laboratories Ltd
NAFDAC
NAFDAC blacklists Onifam Laboratories Ltd and associated persons/entities from pharmaceutical business activities due to regulatory misrepresentation and improper use of approvals.
Businesses dealing with Onifam Laboratories may face supply chain disruptions; all pharmaceutical entities must ensure transparent regulatory compliance to avoid similar actions.
Public Alert No. 037/2026 – Alert on Suspected Counterfeit Pulmicort® (Budesonide) Inhalation Suspension
NAFDAC
NAFDAC alerts the public to suspected counterfeit Pulmicort® (Budesonide) inhalation suspension in the market, infringing on AstraZeneca's authorization.
Pharmacies, hospitals, and distributors must verify product authenticity and report suspicious products to NAFDAC to avoid legal and safety risks.
Public Alert No. 036/2026 – Alert on Suspected Counterfeit Products Mimicking Forxiga® (Dapagliflozin)
NAFDAC
NAFDAC alerts the public to suspected counterfeit Forxiga® (dapagliflozin) products in the market, infringing on AstraZeneca's authorization.
Similar to the Pulmicort alert, this requires heightened vigilance among pharmaceutical supply chain stakeholders to prevent distribution of counterfeit products.
SON rides on e-platform to facilitate international trade - Business News Nigeria
Other
SON is using an e-platform to facilitate international trade, likely streamlining certification and standards compliance processes.
Businesses involved in international trade may benefit from faster, more transparent SON processes, but should verify current platform features and requirements.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide - within nigeria
Other
A guide on registering fish farms with NEPC for export purposes, highlighting the process and benefits.
Fish farmers and exporters can leverage NEPC registration to access export incentives and expand market reach, but must comply with NEPC requirements.
Heightened enforcement against counterfeit drugs and regulatory non-compliance.
Increased scrutiny of pharmaceutical supply chains and product authenticity.
Potential for stricter regulations on infant nutrition and medical devices.
Opportunities for digital trade facilitation through SON e-platform.
Export opportunities for fish farmers through NEPC registration.
1
Review and strengthen internal quality assurance and traceability systems for pharmaceutical and medical device products.
2
Implement robust adverse event and complaint handling procedures in line with NAFDAC guidance.
3
Verify the authenticity of all pharmaceutical products before distribution and report suspected counterfeits to NAFDAC.
4
Ensure all regulatory approvals and certificates are valid and used appropriately to avoid blacklisting.
5
Monitor NAFDAC alerts and public notices regularly for updates on counterfeit products and regulatory changes.
6
For fish farmers, consider registering with NEPC to access export incentives and comply with export requirements.
7
Explore SON's e-platform for streamlined trade facilitation and ensure compliance with SON standards.